We are live on
!
Find out more
Aurinia Pharmaceuticals
AUPH
AUPH
189 hedge funds and large institutions have $421M invested in Aurinia Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 57 increasing their positions, 54 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
87% more call options, than puts
Call options by funds: $23.8M | Put options by funds: $12.7M
3.61% more ownership
Funds ownership: 35.8% → 39.41% (+3.6%)
6% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 54
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 199 → 189 (-10)
18% less capital invested
Capital invested by funds: $510M → $421M (-$89.8M)
26% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 31
Holders
189
Holders Change
-10
Holders Change %
-5.03%
% of All Funds
3.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
57
Reduced
54
Closed
31
Calls
$23.8M
Puts
$12.7M
Net Calls
+$11.1M
Net Calls Change
-$404K
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$49.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$16.3M |
| 3 |
AC
Armistice Capital
New York
|
+$6.27M |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$4.91M |
| 5 |
Two Sigma Investments
New York
|
+$4.54M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$12.3M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.14M |
| 3 |
N
Natixis
Paris,
France
|
-$7.55M |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$5.87M |
| 5 |
Barclays
London,
United Kingdom
|
-$3.33M |
